125 related articles for article (PubMed ID: 20649629)
21. Glargine vs. NPH insulin therapy in pregnancies complicated by diabetes: an observational cohort study.
Negrato CA; Rafacho A; Negrato G; Teixeira MF; Araújo CA; Vieira L; Silva CA; Date SK; Demarchi AC; Gomes MB
Diabetes Res Clin Pract; 2010 Jul; 89(1):46-51. PubMed ID: 20378197
[TBL] [Abstract][Full Text] [Related]
22. The safety profile of exogenous insulin in people with type 2 diabetes: justification for concern.
Currie CJ; Johnson JA
Diabetes Obes Metab; 2012 Jan; 14(1):1-4. PubMed ID: 21736688
[TBL] [Abstract][Full Text] [Related]
23. Basal insulin glargine vs prandial insulin lispro in type 2 diabetes.
Oliveira JH; Kazda C; Simpson A; Jackson JA; Heine RJ
Lancet; 2008 Aug; 372(9636):371-2; author reply 372. PubMed ID: 18675683
[No Abstract] [Full Text] [Related]
24. [Multiple insulin injections therapy as an intensive insulin therapy].
Kishikawa H; Wake N; Shichiri M
Nihon Rinsho; 1997 Nov; 55 Suppl():249-54. PubMed ID: 9434476
[No Abstract] [Full Text] [Related]
25. Medically minimising the impact of hypoglycaemia in type 2 diabetes: a review.
Noh RM; Graveling AJ; Frier BM
Expert Opin Pharmacother; 2011 Oct; 12(14):2161-75. PubMed ID: 21668402
[TBL] [Abstract][Full Text] [Related]
26. Increase of body weight during the first year of intensive insulin treatment in type 2 diabetes: systematic review and meta-analysis.
Pontiroli AE; Miele L; Morabito A
Diabetes Obes Metab; 2011 Nov; 13(11):1008-19. PubMed ID: 21645195
[TBL] [Abstract][Full Text] [Related]
27. Good glycemic control with flexibility in timing of basal insulin supply: a 24-week comparison of insulin glargine given once daily in the morning or at bedtime in combination with morning glimepiride.
Standl E; Maxeiner S; Raptis S; Karimi-Anderesi Z; Schweitzer MA;
Diabetes Care; 2005 Feb; 28(2):419-20. PubMed ID: 15677803
[No Abstract] [Full Text] [Related]
28. [Hypoglycemia could increase the risk of arrhythmia in diabetics, explaining the increased cardiovascular mortality in the intensive control of blood glucose].
Chanson P; Pariente A
Rev Prat; 2014 May; 64(5):614. PubMed ID: 24923040
[No Abstract] [Full Text] [Related]
29. Insulin glulisine may ameliorate nocturnal hypoglycemia related to insulin antibody--a case report.
Itoh A; Saisho Y; Mitsuishi M; Oikawa Y; Kawai T; Tanaka M; Shimada A; Itoh H
Diabetes Res Clin Pract; 2011 Nov; 94(2):e53-4; discussion e55. PubMed ID: 21724289
[No Abstract] [Full Text] [Related]
30. Insulin regimens in type 2 diabetes.
Lund SS; Vaag AA
N Engl J Med; 2010 Mar; 362(10):959; author reply 960. PubMed ID: 20220196
[No Abstract] [Full Text] [Related]
31. [Prevention of insulin-induced hypoglycaemia in the elderly].
de Galan BE
Ned Tijdschr Geneeskd; 2014; 158():A7722. PubMed ID: 24975981
[TBL] [Abstract][Full Text] [Related]
32. Patient-centred treatments for type 2 diabetes.
Kudva YC; Montori VM
Lancet; 2008 Mar; 371(9618):1047-8. PubMed ID: 18374823
[No Abstract] [Full Text] [Related]
33. [Insulin glargine and cancer: a storm in a glass of water?].
Scheen AJ; Lefebvre PJ
Rev Med Liege; 2009 Sep; 64(9):440-5. PubMed ID: 19947313
[TBL] [Abstract][Full Text] [Related]
34. Risk of hypoglycaemia in type 2 diabetes patients under different insulin regimens: a primary care database analysis.
Kostev K; Dippel FW; Rathmann W
Ger Med Sci; 2015; 13():Doc01. PubMed ID: 25698911
[TBL] [Abstract][Full Text] [Related]
35. [Adverse effects of insulin].
Uchigata Y
Nihon Rinsho; 2007 Oct; 65 Suppl 8():173-7. PubMed ID: 18074534
[No Abstract] [Full Text] [Related]
36. Insulin therapy in type 2 diabetes: a reflection on the state of the art today and the potential journeys yet to come.
Sorli C
Am J Med; 2014 Oct; 127(10 Suppl):S1-2. PubMed ID: 25282007
[No Abstract] [Full Text] [Related]
37. Intensive insulin for type 2 diabetes: the risk of causing harm.
Nolan CJ; Ruderman NB; Prentki M
Lancet Diabetes Endocrinol; 2013 Sep; 1(1):9-10. PubMed ID: 24622256
[No Abstract] [Full Text] [Related]
38. Insulin glargine and cancer.
Hemkens LG; Bender R; Grouven U; Sawicki PT
Lancet; 2009 Nov; 374(9703):1743-4; author reply 1744. PubMed ID: 19932352
[No Abstract] [Full Text] [Related]
39. The international study of insulin and cancer.
Grimaldi-Bensouda L; Marty M; Pollak M; Cameron D; Riddle M; Charbonnel B; Barnett AH; Boffetta P; Boivin JF; Evans M; Rossignol M; Benichou J; Abenhaim L;
Lancet; 2010 Sep; 376(9743):769-70. PubMed ID: 20816540
[No Abstract] [Full Text] [Related]
40. Hypoglycaemia: a therapeutic concern in type 2 diabetes.
Garber AJ
Lancet; 2012 Jun; 379(9833):2215-6. PubMed ID: 22704156
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
